The high presence of neutralizing antibodies against the SARS‐CoV‐2 spike protein among asymptomatic populations in N’Djamena could explain the low prevalence and low severity of Covid‐19 observed in these areas, as these neutralizing antibodies play a key role in blocking SARS‐Cov‐2 infection. Moreover, the commercial tests available (Abbott Alinity i and Roche Elecsys®) for the detection of these receptor‐binding domain antibodies (anti‐RBDs) showed acceptable performance when compared with the pseudovirus neutralization test.
All Keywords
【저자키워드】 Neutralizing antibodies, Asymptomatic individuals, anti‐receptor‐binding domain antibodies, N'Djamena,
【저자키워드】 Neutralizing antibodies, Asymptomatic individuals, anti‐receptor‐binding domain antibodies, N'Djamena,